24 related articles for article (PubMed ID: 38505996)
21. Second generation anti-androgens and androgen deprivation therapy with radiation therapy in the definitive management of high-risk prostate cancer.
Wang EC; Lee WR; Armstrong AJ
Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):30-40. PubMed ID: 36203051
[TBL] [Abstract][Full Text] [Related]
22. Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers.
Fang D; Zhou L
Asia Pac J Clin Oncol; 2019 Jun; 15(3):108-120. PubMed ID: 30729683
[TBL] [Abstract][Full Text] [Related]
23. An evidence review of active surveillance in men with localized prostate cancer.
Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
[TBL] [Abstract][Full Text] [Related]
24. Management Options for Biochemically Recurrent Prostate Cancer.
Fakhrejahani F; Madan RA; Dahut WL
Curr Treat Options Oncol; 2017 May; 18(5):26. PubMed ID: 28434181
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
